UPClytics
EnglishDeutsch
Sign inSign up
View all cases

UPC APP 3053/2025

Jan 21, 2025·EP3167888: TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS BY AN INHIBITOR OF COMPLEMENT

Case details
Status
Case Closed
Action
Generic
Category
Other Procedural
Parties
Claimants
Reps: Tilman Mueller-Stoy
Respondents
Reps: Elena Hennecke
Division
Hamburg LD
Judges
Technology
Organic Chemistry
Language
English
Documents
Document titleDatePublic
action.phaseChange.caseClose2025-12-05Not public
action.issueOrder.order2025-12-02Not public
Order2025-12-02Not public
Cover sheet2025-11-26Not public
Further pleadings2025-11-26Not public
Receipt2025-11-26Not public
Cover sheet2025-11-25Not public
Application document Claimant2025-11-25Not public
Receipt2025-11-25Not public
action.issueOrder.order2025-11-18Not public
Order2025-11-18Not public
Application document Defendant2025-11-13Not public
Other document Defendant2025-11-13Not public
Cover sheet2025-11-13Not public
Other document Defendant2025-11-13Not public
Other document Defendant2025-11-13Not public
Other document Defendant2025-11-13Not public
Other document Defendant2025-11-13Not public
Receipt2025-11-13Not public
action.issueOrder.order2025-10-21Not public
Order2025-10-21Not public
action.communication.general2025-10-20Not public
Application2025-10-16Not public
Other document2025-10-16Not public
Cover sheet2025-10-16Not public
Other document2025-10-16Not public
Receipt2025-10-16Not public
action.issueOrder.order2025-10-08Not public
Order2025-10-08Not public
Application2025-10-02Not public
Application2025-10-02Not public
Cover sheet2025-10-02Not public
Other document2025-10-02Not public
Receipt2025-10-02Not public
Outcome of the Order2025-09-17Not public
rectification2025-09-17Not public
Outcome of the Order2025-09-10Not public
Deadline extension2025-09-10Not public
Receipt2025-09-10Not public
Receipt2025-09-10Not public
Receipt2025-09-10Not public
262.2 Application2025-09-09Not public
Deadline extension request2025-09-09Not public
Deadline extension request2025-09-09Not public
Application_for_rectification_ORD_35478_20252025-09-09Not public
Anhoerung2025-09-04Not public
Outcome of the Order2025-09-04Not public
Order with grounds2025-09-04Not public
Order with grounds2025-09-04Not public
Order with grounds2025-09-04Not public
Order with grounds2025-09-04Not public
20250903_Second_Instance_Costs_Confidentiality_Reply_Amgen signed2025-09-03Not public
20250903_Second_Instance_Costs_Confidentiality_Reply_Amgen signed2025-09-03Not public
20250903_Second_Instance_Costs_Confidentiality_Reply_Amgen signed2025-09-03Not public
20250903_Second_Instance_Costs_Confidentiality_Reply_Amgen signed2025-09-03Not public
20250903_Second_Instance_Costs_Confidentiality_Reply_Amgen signed2025-09-03Not public
20250903_Second_Instance_Costs_Confidentiality_Reply_Amgen signed2025-09-03Not public
20250903_Second_Instance_Costs_Confidentiality_Reply_Amgen signed2025-09-03Not public
20250903_Second_Instance_Costs_Confidentiality_Reply_Amgen signed2025-09-03Not public
20250903_Second_Instance_Costs_Confidentiality_Reply_Amgen signed2025-09-03Not public
Anhoerung2025-08-31Not public
Comments2025-08-28Not public
Anhoerung2025-08-25Not public
Receipt2025-08-21Not public
20250820_Confidentiality_Applications_262_2_262_A_Second_Instance_costs_Amgen signed2025-08-20Not public
20250820_Confidentiality_Applications_262_2_262_A_Second_Instance_costs_Amgen signed2025-08-20Not public
20250820_Second_Instance_Costs_Reply_Amgen_3053_2025_Confidential signed2025-08-20Not public
Exhibit_BP_KF01_Amgen_3053_20252025-08-20Not public
20250820_Second_Instance_Costs_Reply_Amgen_3053_2025_Confidential signed2025-08-20Not public
20250820_Second_Instance_Costs_Reply_Amgen_3053_2025_Confidential signed2025-08-20Not public
20250820_Second_Instance_Costs_Reply_Amgen_3053_2025_Confidential signed2025-08-20Not public
Exhibit_BP_KF01_Amgen_3053_20252025-08-20Not public
Exhibit_BP_KF01_Amgen_3053_20252025-08-20Not public
20250820_Second_Instance_Costs_Reply_Amgen_3053_2025_Confidential signed2025-08-20Not public
20250820_Second_Instance_Costs_Reply_Amgen_3053_2025_Confidential signed2025-08-20Not public
20250820_Second_Instance_Costs_Reply_Amgen_3053_2025_Confidential signed2025-08-20Not public
20250820_Second_Instance_Costs_Reply_Amgen_3053_2025_Confidential signed2025-08-20Not public
Exhibit_BP_KF01_Amgen_3053_20252025-08-20Not public
20250820_Second_Instance_Costs_Reply_Amgen_3053_2025_Confidential signed2025-08-20Not public
Exhibit_BP_KF01_Amgen_3053_20252025-08-20Not public
20250820_Second_Instance_Costs_Reply_Amgen_3053_2025_Confidential signed2025-08-20Not public
20250820_Second_Instance_Costs_Reply_Amgen_3053_2025_Confidential signed2025-08-20Not public
20250820_Second_Instance_Costs_Reply_Amgen_3053_2025_Confidential signed2025-08-20Not public
Exhibit_BP_KF01_Amgen_3053_20252025-08-20Not public
Exhibit_BP_KF01_Amgen_3053_20252025-08-20Not public
20250820_Second_Instance_Costs_Reply_Amgen_3053_2025_Confidential signed2025-08-20Not public
20250820_Second_Instance_Costs_Reply_Amgen_3053_2025_Confidential signed2025-08-20Not public
20250820_Second_Instance_Costs_Reply_Amgen_3053_2025_Confidential signed2025-08-20Not public
Exhibit_BP_KF01_Amgen_3053_20252025-08-20Not public
20250820_Second_Instance_Costs_Reply_Amgen_3053_2025_Confidential signed2025-08-20Not public
20250820_Second_Instance_Costs_Reply_Amgen_3053_2025_Confidential signed2025-08-20Not public
20250820_Second_Instance_Costs_Reply_Amgen_3053_2025_Confidential signed2025-08-20Not public
Exhibit_BP_KF01_Amgen_3053_20252025-08-20Not public
Anhoerung2025-08-06Not public
Comments2025-07-14Not public
Anhoerung2025-07-02Not public
Receipt2025-01-21Not public
Application2025-01-20Not public